{"title":"根据临床适应症调整tips后的血流动力学目标:静脉曲张出血vs.难治性腹水","authors":"Yong Lv, Zhengyu Wang, Bohan Luo, Guohong Han","doi":"10.1016/j.jhep.2025.02.036","DOIUrl":null,"url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Adjustments to PPG During the Second Measurement</h2>Zipprich et al. note that adjustments to the portal pressure gradient (PPG) in our cohort were limited to cases of suboptimal stent positioning or stenosis/occlusion, rather than PPG exceeding the target range. This approach aligns with the primary objective of our study: to identify optimal timing and hemodynamic targets for PPG measurement post-TIPS, not to evaluate intervention efficacy<sup>[1]</sup>. To preserve the natural trajectory of PPG evolution and avoid confounding effects, we deliberately</section></section><section><section><h2>Discrepancy in Outcomes with the 7–14 mmHg Target Range</h2>Zipprich et al. report no survival or decompensation differences using a 7–14 mmHg target in their cohort (n=84), contrasting with our findings. Two factors likely explain this divergence: a) Population Heterogeneity: Our cohort exclusively included patients with variceal bleeding, whereas Zipprich et al. enrolled a mixed population (71% refractory ascites). These groups exhibit distinct hemodynamic profiles. For bleeding, excessive PPG reduction (<10 mmHg) risks hepatic encephalopathy (OHE)</section></section><section><section><h2>Authors' contributions</h2>Yong Lv, Zhengyu Wang, Bohan Luo and Guohong Han designed the letter; Yong Lv drafted the letter; Guohong Han revised the letter.</section></section><section><section><h2>Financial support</h2>None.</section></section><section><section><h2>Declaration of Competing Interest</h2>All authors have nothing to declare.Please refer to the accompanying ICMJE disclosure forms for further details.</section></section><section><section><h2>Acknowledgements</h2>None.</section></section>","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":"27 1","pages":""},"PeriodicalIF":26.8000,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Tailoring Post-TIPS Hemodynamic Targets to Clinical Indications: Variceal Bleeding vs. Refractory Ascites\",\"authors\":\"Yong Lv, Zhengyu Wang, Bohan Luo, Guohong Han\",\"doi\":\"10.1016/j.jhep.2025.02.036\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<h2>Section snippets</h2><section><section><h2>Adjustments to PPG During the Second Measurement</h2>Zipprich et al. note that adjustments to the portal pressure gradient (PPG) in our cohort were limited to cases of suboptimal stent positioning or stenosis/occlusion, rather than PPG exceeding the target range. This approach aligns with the primary objective of our study: to identify optimal timing and hemodynamic targets for PPG measurement post-TIPS, not to evaluate intervention efficacy<sup>[1]</sup>. To preserve the natural trajectory of PPG evolution and avoid confounding effects, we deliberately</section></section><section><section><h2>Discrepancy in Outcomes with the 7–14 mmHg Target Range</h2>Zipprich et al. report no survival or decompensation differences using a 7–14 mmHg target in their cohort (n=84), contrasting with our findings. Two factors likely explain this divergence: a) Population Heterogeneity: Our cohort exclusively included patients with variceal bleeding, whereas Zipprich et al. enrolled a mixed population (71% refractory ascites). These groups exhibit distinct hemodynamic profiles. For bleeding, excessive PPG reduction (<10 mmHg) risks hepatic encephalopathy (OHE)</section></section><section><section><h2>Authors' contributions</h2>Yong Lv, Zhengyu Wang, Bohan Luo and Guohong Han designed the letter; Yong Lv drafted the letter; Guohong Han revised the letter.</section></section><section><section><h2>Financial support</h2>None.</section></section><section><section><h2>Declaration of Competing Interest</h2>All authors have nothing to declare.Please refer to the accompanying ICMJE disclosure forms for further details.</section></section><section><section><h2>Acknowledgements</h2>None.</section></section>\",\"PeriodicalId\":15888,\"journal\":{\"name\":\"Journal of Hepatology\",\"volume\":\"27 1\",\"pages\":\"\"},\"PeriodicalIF\":26.8000,\"publicationDate\":\"2025-02-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Hepatology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jhep.2025.02.036\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jhep.2025.02.036","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
Tailoring Post-TIPS Hemodynamic Targets to Clinical Indications: Variceal Bleeding vs. Refractory Ascites
Section snippets
Adjustments to PPG During the Second Measurement
Zipprich et al. note that adjustments to the portal pressure gradient (PPG) in our cohort were limited to cases of suboptimal stent positioning or stenosis/occlusion, rather than PPG exceeding the target range. This approach aligns with the primary objective of our study: to identify optimal timing and hemodynamic targets for PPG measurement post-TIPS, not to evaluate intervention efficacy[1]. To preserve the natural trajectory of PPG evolution and avoid confounding effects, we deliberately
Discrepancy in Outcomes with the 7–14 mmHg Target Range
Zipprich et al. report no survival or decompensation differences using a 7–14 mmHg target in their cohort (n=84), contrasting with our findings. Two factors likely explain this divergence: a) Population Heterogeneity: Our cohort exclusively included patients with variceal bleeding, whereas Zipprich et al. enrolled a mixed population (71% refractory ascites). These groups exhibit distinct hemodynamic profiles. For bleeding, excessive PPG reduction (<10 mmHg) risks hepatic encephalopathy (OHE)
Authors' contributions
Yong Lv, Zhengyu Wang, Bohan Luo and Guohong Han designed the letter; Yong Lv drafted the letter; Guohong Han revised the letter.
Financial support
None.
Declaration of Competing Interest
All authors have nothing to declare.Please refer to the accompanying ICMJE disclosure forms for further details.
期刊介绍:
The Journal of Hepatology is the official publication of the European Association for the Study of the Liver (EASL). It is dedicated to presenting clinical and basic research in the field of hepatology through original papers, reviews, case reports, and letters to the Editor. The Journal is published in English and may consider supplements that pass an editorial review.